— Know what they know.
Not Investment Advice

IDYA Short Interest

IDEAYA Biosciences, Inc.
1W: -5.3% 1M: -12.3% 3M: -5.9% YTD: -1.0% 1Y: +14.8% 3Y: +32.5% 5Y: +46.5%
$33.50
+0.62 (+1.89%)
 
Weekly Expected Move ±5.7%
$31 $33 $35 $37 $39
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · $3.2B mcap · 90M float · 1.03% daily turnover · Short 60% of daily vol
Credit Risk of going bust: lower than 86% of companies Debt: 0.9% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.03 (down 99.9%), IDEAYA Biosciences, Inc. would be worth roughly what it owes.
Total debt $29.3M against a stock market value of $3.23B.
Distance to default 11.80 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $14.7M (short-term plus half of long-term), stock volatility 45.4%; Altman Z'' 11.92. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-26
62.4%
Short Ratio
of total volume
66.5%
20-Day Avg
65.2%
50-Day Avg
▲ Rising
5-Day Trend
0.3M
Short Volume
0.5M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 272,455 446,096 61.1%
NYSE 15,843 16,298 97.2%
BATS 650 827 78.6%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms